Skip to main content

Table 3 Chemotherapy-related toxicity in all patients

From: Efficacy and safety of modified bleomycin administration with EP chemotherapy in adult male patients with germ cell tumors: a retrospective study

Toxicity

Any Grade, n (%)

G3-G4, n (%)

Any adverse event

239(87.23%)

123(44.89%)

Hematologic

 Neutropenia

159(58.03%)

107(39.05%)

 Febrile neutropenia

18(6.57%)

18(6.57%)

 Anemia

132(48.18%)

13(4.74%)

 Thrombocytopenia

40(14.6%)

14(5.11%)

Nonhematologic

 Dyspepsia

77(28.1%)

0

 Vomiting

46(16.79%)

0

 Nausea

80(29.2%)

0

 Mucositis

7(2.55%)

0

 Diarrhea

7(2.55%)

0

 Pneumonia

4(1.46%)

1(0.37%)

 Rash

3(1.09%)

0

 Alopecia

18(6.57%)

2(0.73%)

 Fatigue

8(2.92%)

0

 Elevated transaminases

58(21.17%)

2(0.73%)

 Serum creatinine increased

18(6.57%)

0